Company page
Palisade Bio, Inc.
Palisade Bio, Inc. is a public company traded under the ticker PALI in the American market. The company has a market capitalization of approximately $324.6 million. Palisade Bio focuses on developing innovative therapies to address unmet medical needs.
- Ticker
- PALI:NASDAQ
- Asset type
- Stock
- Market cap
- $324.6M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD